These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9372217

  • 1. Dopamine receptor-mediated regulation of expression of Fos and its related antigens (FRA) in somatostatin neurons in the hypothalamic periventricular nucleus.
    Cheung S, Johnson JD, Moore KE, Lookingland KJ.
    Brain Res; 1997 Oct 03; 770(1-2):176-83. PubMed ID: 9372217
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of dopamine D1 receptors increases activity of periventricular somatostatin neurons and suppress concentrations of growth hormone.
    McMahon CD, Chapin LT, Lookingland KJ, Tucker HA.
    Domest Anim Endocrinol; 1998 Jul 03; 15(4):257-65. PubMed ID: 9673457
    [Abstract] [Full Text] [Related]

  • 3. Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer.
    Perreault ML, Shen MY, Fan T, George SR.
    Neuroscience; 2015 Jan 29; 285():194-203. PubMed ID: 25446350
    [Abstract] [Full Text] [Related]

  • 4. Differing influences of dopamine agonists and antagonists on Fos expression in identified populations of globus pallidus neurons.
    Ruskin DN, Marshall JF.
    Neuroscience; 1997 Nov 29; 81(1):79-92. PubMed ID: 9300403
    [Abstract] [Full Text] [Related]

  • 5. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O, Biggio G.
    Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234
    [Abstract] [Full Text] [Related]

  • 6. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
    Alonso R, Gnanadicom H, Fréchin N, Fournier M, Le Fur G, Soubrié P.
    Eur J Neurosci; 1999 Mar 12; 11(3):967-74. PubMed ID: 10103090
    [Abstract] [Full Text] [Related]

  • 7. D1 dopamine receptor agonist (SKF-38393) induction of Fos immunoreactivity in progestin receptor-containing areas of female rat brain.
    Meredith JM, Auger AP, Blaustein JD.
    J Neuroendocrinol; 1997 May 12; 9(5):385-94. PubMed ID: 9181492
    [Abstract] [Full Text] [Related]

  • 8. Effects of prolactin on expression of Fos-related antigens in tyrosine hydroxylase-immunoreactive neurons in subdivisions of the arcuate nucleus.
    Hentschel K, Moore KE, Lookingland KJ.
    Brain Res; 2000 Feb 28; 857(1-2):110-8. PubMed ID: 10700558
    [Abstract] [Full Text] [Related]

  • 9. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ, Yu J, Marshall JF.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7451-5. PubMed ID: 8102797
    [Abstract] [Full Text] [Related]

  • 10. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
    Izquierdo-Claros RM, del Boyano-Adánez M, Arilla-Ferreiro E.
    J Neurosci Res; 2000 Oct 01; 62(1):91-8. PubMed ID: 11002291
    [Abstract] [Full Text] [Related]

  • 11. Opposing roles for dopamine D1 and D2 receptors in the regulation of hypothalamic tuberoinfundibular dopamine neurons.
    Durham RA, Johnson JD, Eaton MJ, Moore KE, Lookingland KJ.
    Eur J Pharmacol; 1998 Aug 21; 355(2-3):141-7. PubMed ID: 9760028
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptor-mediated regulation of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus.
    Eaton MJ, Cheung S, Moore KE, Lookingland KJ.
    Brain Res; 1996 Oct 28; 738(1):60-6. PubMed ID: 8949928
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Do D1/D2 interactions regulate prepulse inhibition in rats?
    Wan FJ, Taaid N, Swerdlow NR.
    Neuropsychopharmacology; 1996 Apr 28; 14(4):265-74. PubMed ID: 8924194
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of growth hormone-releasing hormone and somatostatin from perifused, bovine hypothalamic slices. II. Dopamine receptor regulation.
    West CR, Lookingland KJ, Tucker HA.
    Domest Anim Endocrinol; 1997 Sep 28; 14(5):349-57. PubMed ID: 9347255
    [Abstract] [Full Text] [Related]

  • 17. D2 inhibition of stimulated Fos immunoreactivity in cultured tyrosine hydroxylase-ir hypothalamic neurons.
    Sim LJ, Selley DE, Tsai KP, Morris M.
    Brain Res; 1994 Jul 18; 651(1-2):311-6. PubMed ID: 7922580
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja.
    Wirtshafter D.
    Synapse; 1998 Feb 18; 28(2):154-9. PubMed ID: 9450515
    [Abstract] [Full Text] [Related]

  • 20. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Lewis BM, Dieguez C, Lewis M, Hall R, Scanlon MF.
    Endocrinology; 1986 Oct 18; 119(4):1712-7. PubMed ID: 2428601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.